ASX - By Stock
|
TLG |
Re:
Ann: Talga Investor Webinar Recording
|
|
Edmorgrimm
|
6 |
2.4K |
43 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
6
|
2.4K
|
43
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
Edmorgrimm
|
71 |
18K |
27 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
71
|
18K
|
27
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Edmorgrimm
|
121 |
48K |
9 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
121
|
48K
|
9
|
|
ASX - By Stock
|
WA8 |
Re:
The Warriedar story just keeps getting better.
|
|
Edmorgrimm
|
88 |
19K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
88
|
19K
|
5
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Edmorgrimm
|
2.7K |
659K |
13 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
2.7K
|
659K
|
13
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Edmorgrimm
|
2.4K |
1.1M |
8 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
8
|
|
ASX - By Stock
|
WA8 |
Re:
The Warriedar story just keeps getting better.
|
|
Edmorgrimm
|
88 |
19K |
5 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
88
|
19K
|
5
|
|
ASX - By Stock
|
WA8 |
Re:
The Warriedar story just keeps getting better.
|
|
Edmorgrimm
|
88 |
19K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
88
|
19K
|
6
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Edmorgrimm
|
2.4K |
1.1M |
3 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Edmorgrimm
|
2.4K |
1.1M |
3 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
3
|
|
International Markets
|
SPR |
Re:
Spartan Resources
|
|
Edmorgrimm
|
513 |
240K |
2 |
01/05/24 |
01/05/24 |
International Markets
|
513
|
240K
|
2
|
|
International Markets
|
SPR |
Re:
Spartan Resources
|
|
Edmorgrimm
|
513 |
240K |
9 |
01/05/24 |
01/05/24 |
International Markets
|
513
|
240K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Edmorgrimm
|
448 |
201K |
3 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
448
|
201K
|
3
|
|
ASX - By Stock
|
SPR |
Re:
Ann: Change in substantial holding
|
|
Edmorgrimm
|
22 |
5.2K |
5 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
22
|
5.2K
|
5
|
|
ASX - By Stock
|
SPR |
Re:
Ann: Change in substantial holding
|
|
Edmorgrimm
|
22 |
5.2K |
4 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
22
|
5.2K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
Edmorgrimm
|
71 |
18K |
10 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
71
|
18K
|
10
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Chart Thread
|
|
Edmorgrimm
|
171 |
49K |
6 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
171
|
49K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
Edmorgrimm
|
71 |
18K |
6 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
71
|
18K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
Edmorgrimm
|
71 |
18K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
71
|
18K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
Edmorgrimm
|
629 |
201K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
629
|
201K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
Edmorgrimm
|
71 |
18K |
13 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
71
|
18K
|
13
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
Edmorgrimm
|
71 |
18K |
15 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
71
|
18K
|
15
|
|
ASX - By Stock
|
TLG |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Edmorgrimm
|
46 |
13K |
36 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
46
|
13K
|
36
|
|
ASX - By Stock
|
NEU |
Re:
PHASE2 PRADER WILLI SYNDROME START !!!!
|
|
Edmorgrimm
|
36 |
24K |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
36
|
24K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
PHASE2 PRADER WILLI SYNDROME START !!!!
|
|
Edmorgrimm
|
36 |
24K |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
36
|
24K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Edmorgrimm
|
194 |
72K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
194
|
72K
|
4
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Edmorgrimm
|
7 |
1.5K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
7
|
1.5K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Edmorgrimm
|
194 |
72K |
8 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
194
|
72K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Edmorgrimm
|
194 |
72K |
26 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
194
|
72K
|
26
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Edmorgrimm
|
194 |
72K |
23 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
194
|
72K
|
23
|
|
ASX - By Stock
|
DXB |
Re:
DJ Dimerix Initiated at A$0.80/Share Price Target by Euroz Hartleys
|
|
Edmorgrimm
|
11 |
5.4K |
7 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
11
|
5.4K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
Edmorgrimm
|
194 |
72K |
27 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
194
|
72K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q1 2024 quarterly activity and cash flow report
|
|
Edmorgrimm
|
15 |
6.7K |
30 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
15
|
6.7K
|
30
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Successful Completion of Retail Entitlement Offer
|
|
Edmorgrimm
|
5 |
1.8K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
5
|
1.8K
|
7
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Edmorgrimm
|
11 |
3.7K |
23 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
11
|
3.7K
|
23
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Edmorgrimm
|
345 |
97K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
345
|
97K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Kidney Disease Drug Candidate Progressing to Human Trials
|
|
Edmorgrimm
|
28 |
9.4K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
28
|
9.4K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
Edmorgrimm
|
48 |
14K |
7 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
48
|
14K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Kidney Disease Drug Candidate Progressing to Human Trials
|
|
Edmorgrimm
|
28 |
9.4K |
4 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
28
|
9.4K
|
4
|
|
ASX - By Stock
|
TLG |
Re:
Ann: Talga Investor Webinar
|
|
Edmorgrimm
|
24 |
11K |
21 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
24
|
11K
|
21
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
Edmorgrimm
|
48 |
14K |
13 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
48
|
14K
|
13
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Kidney Disease Drug Candidate Progressing to Human Trials
|
|
Edmorgrimm
|
28 |
9.4K |
16 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
28
|
9.4K
|
16
|
|
ASX - By Stock
|
WA8 |
Re:
The Warriedar story just keeps getting better.
|
|
Edmorgrimm
|
88 |
19K |
2 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
88
|
19K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Edmorgrimm
|
2.4K |
1.1M |
19 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
2.4K
|
1.1M
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Edmorgrimm
|
9.9K |
4.4M |
24 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
24
|
|
ASX - By Stock
|
WA8 |
Re:
The Warriedar story just keeps getting better.
|
|
Edmorgrimm
|
88 |
19K |
12 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
88
|
19K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Edmorgrimm
|
9.9K |
4.4M |
32 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
32
|
|
ASX - By Stock
|
WA8 |
Re:
Ann: ********* Hidden Gems Webinar Presentation
|
|
Edmorgrimm
|
9 |
2.3K |
7 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
9
|
2.3K
|
7
|
|
ASX - By Stock
|
WA8 |
Re:
Ann: ********* Hidden Gems Webinar Presentation
|
|
Edmorgrimm
|
9 |
2.3K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
9
|
2.3K
|
2
|
|
ASX - By Stock
|
TLG |
Re:
TLG - Media
|
|
Edmorgrimm
|
15K |
4.9M |
20 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
15K
|
4.9M
|
20
|
|